News &amp; Updates

Obesity during childhood appears to have an impact on penile growth, while obesity in adulthood influences the appearance of the penis rather than its actual size, reveals a study.

Childhood obesity may affect penis size

Mindfulness may improve daily sexual function

Mindfulness helps promote present-moment awareness in daily sexual interaction, which potentially boosts sexual function, according to a study.

Mindfulness may improve daily sexual function

Midline extraction incision predicts incisional hernia risk after nephrectomy

A midline extraction incision appears to contribute to a greater risk of incisional hernia (IH) following a minimally invasive nephrectomy, according to a study.

Midline extraction incision predicts incisional hernia risk after nephrectomy

Rocatinlimab delivers in ROCKET-SHUTTLE trial

Findings from the phase III ROCKET-SHUTTLE trial support the treatment potential of rocatinlimab for atopic dermatitis (AD).

Rocatinlimab delivers in ROCKET-SHUTTLE trial

03 Oct 2025

Stroke during pregnancy makes subsequent pregnancies high-risk

Women who have had an ischaemic stroke (IS) during a pregnancy face increased risk of complications in subsequent pregnancies, according to a study.

Stroke during pregnancy makes subsequent pregnancies high-risk

ESC 2025: Semaglutide cuts MACE risk by 57 percent vs tirzepatide in patients with obesity and ASCVD

Compared with tirzepatide, subcutaneous semaglutide 2.4 mg is associated with a 57 percent lower risk of revised 3-point major adverse cardiovascular events (3P-MACE; defined as MI, stroke, and all-cause mortality [instead of cardiovascular-related death]) in a population similar to the SELECT trial — patients with overweight or obesity and established atherosclerotic cardiovascular disease (ASCVD) but no history of diabetes, according to results of the real-world STEER trial presented at the European Society of Cardiology (ESC) Congress 2025.

ESC 2025: Semaglutide cuts MACE risk by 57 percent vs tirzepatide in patients with obesity and ASCVD

Metronomic chemo in HR+, HER2- advanced breast cancer after ET

Metronomic chemotherapy (MCT) has gained popularity for maintaining disease control with a more favourable toxicity profile than conventional chemotherapy. In an interview with MIMS Oncology, Dr Michael Cheung, Specialist in Clinical Oncology in private practice in Hong Kong, discussed its benefits for patients with hormone receptor positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC) who have failed endocrine therapy (ET).

Metronomic chemo in HR+, HER2- advanced breast cancer after ET

Premenstrual disorders harm quality of life

Premenstrual disorders, especially premenstrual dysphoric disorder, are associated with reduced quality of life in women, according to a cross-sectional study from Sweden.

Premenstrual disorders harm quality of life

ATTAIN-1: GLP-1RA pill confers weight-loss benefits in adults with obesity

02 Oct 2025 by

In adults with obesity but without diabetes, treatment with the oral small-molecule, nonpeptide glucagon-like peptide-1 receptor agonist (GLP-1RA) orforglipron yields substantial reductions in body weight, as shown in the phase III ATTAIN-1 trial.

ATTAIN-1: GLP-1RA pill confers weight-loss benefits in adults with obesity

DOAC vs warfarin: Which agent is safer for AF patients with cirrhosis?

The use of direct oral anticoagulants (DOACs) appears to be safer than warfarin for patients with nonvalvular atrial fibrillation (AF) and liver cirrhosis (LC), suggests a study. This is particularly true to reducing the risk of major bleeding in those with Child-Pugh class A disease.

DOAC vs warfarin: Which agent is safer for AF patients with cirrhosis?